ARCHIVES

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

ACS Research Budget Over $82 Million

July 17, 1987

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002